Senti Biosciences, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.973
+0.008 (0.81%)
At close: Mar 9, 2026, 4:00 PM EDT
1.000
+0.027 (2.78%)
After-hours: Mar 9, 2026, 7:24 PM EDT
Senti Biosciences Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 26 | 16 | 29 | 62 | 291 | - | |
| Market Cap Growth | 32.71% | -45.22% | -52.46% | -78.72% | - | - | |
| Enterprise Value | 43 | 40 | 27 | -21 | - | - | |
| Last Close Price | 0.96 | 3.51 | 6.60 | 14.10 | 98.60 | - | |
| PS Ratio | - | - | 11.48 | 14.43 | 105.23 | - | |
| PB Ratio | 3.12 | 0.32 | 0.44 | 0.49 | 4.81 | - | |
| P/TBV Ratio | 3.21 | 0.63 | 0.44 | 0.49 | - | - | |
| EV/Sales Ratio | - | - | 10.40 | - | - | - | |
| Debt / Equity Ratio | 3.71 | 0.66 | 0.56 | 0.29 | 0.38 | 0.45 | |
| Net Debt / Equity Ratio | 2.14 | -0.29 | 0.03 | -0.49 | -0.57 | -0.53 | |
| Net Debt / EBITDA Ratio | -0.31 | 0.30 | -0.03 | 1.03 | 0.87 | 0.68 | |
| Net Debt / FCF Ratio | -0.34 | 0.36 | -0.03 | 0.82 | 0.86 | 0.65 | |
| Asset Turnover | - | - | 0.02 | 0.03 | 0.04 | 0.01 | |
| Quick Ratio | 1.21 | 3.84 | 4.24 | 5.56 | 3.97 | 6.35 | |
| Current Ratio | 1.51 | 4.49 | 5.62 | 5.68 | 4.14 | 6.52 | |
| Return on Equity (ROE) | -394.62% | -89.73% | -85.91% | -52.94% | -121.15% | -81.21% | |
| Return on Assets (ROA) | -67.77% | -31.22% | -26.83% | -27.97% | -34.86% | -36.66% | |
| Return on Capital Employed (ROCE) | -147.20% | -64.10% | -60.30% | -38.10% | -49.20% | -56.80% | |
| Earnings Yield | -192.50% | -327.76% | -241.69% | -94.13% | -19.04% | - | |
| FCF Yield | -193.18% | -257.19% | -219.16% | -123.34% | -13.83% | - | |
| Buyback Yield / Dilution | -269.32% | -3.58% | -69.93% | -796.58% | 78.99% | -2.03% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.